Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder
Phase 3
Completed
- Conditions
- Bipolar I Disorder
- Registration Number
- NCT00046384
- Brief Summary
The purpose of this study is to learn if aripiprazole is effective in the treatment of patients with acute symptoms of Bipolar Disorder.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of aripiprazole in treating Bipolar I Disorder symptoms?
How does aripiprazole compare to other antipsychotics in managing acute bipolar episodes?
What biomarkers correlate with aripiprazole response in NCT00046384 bipolar disorder trials?
What adverse events were reported in Otsuka's phase 3 aripiprazole bipolar disorder study?
Are there combination therapies involving aripiprazole for acute bipolar disorder treatment?
Trial Locations
- Locations (1)
Local Institution
🇦🇷Mendoza, Argentina
Local Institution🇦🇷Mendoza, Argentina